Professor Anthony King
MB, BAO, BCh, FRCOphth, MD, MMedSci
I qualified from University College Galway in 1987 and undertook my ophthalmology postgraduate training in the UK.
I was awarded an MD “Progression to blindness in Glaucoma” from the University of Leicester and undertook fellowship training in Glaucoma in London at the Western Ophthalmic and Anterior Segment and Cornea in Nottingham.
I am currently a consultant ophthalmologist with a subspecialist interest in glaucoma at Nottingham University Hospital and an Honorary Professor of Ophthalmology at the University of Nottingham.
My primary research interest is in the clinical management of glaucoma particularly advanced glaucoma. I have received research funding support from the NIHR-HTA program and the International Glaucoma Association.
I am currently the Chief Investigator of the NIHR funded Treatment of Advanced Glaucoma Study (TAGS) and the IGA funded Evaluation of Ocular Surface Inflammation Study.
I have published extensively and lectured throughout the UK and Europe. I'm a past Chairman of the UK and Eire Glaucoma Society and currently the Royal College of Ophthalmologist glaucoma lead for development of a National Ophthalmic Database.
Some of the principal treatments carried out by Professor Anthony King at Spire include:
COVID-19 testing or antibody tests are not available as a standalone service at Spire Nottingham Hospital.
MB BCh BAO / University College Galway / 1987
Bachelor of Medicine, Surgery and Obstetrics
FRCOphth / London / 1992
Royal College of Ophthalmologists
Royal College of Ophthalmology